Now, in regards to the failed sphincter function after different NSAIDs, and later, to the improved sphincter function and smooth muscle function when BPC 157 was given, BPC 157, as a particular anti-ulcer pentadecapeptide, LD1 could be not achieved, effective alone without carrier (1-7) may be a suitable peptide candidate to additionally rescue such extended NSAIDs toxicity (1-14)
The "right" dose sits in a narrow window that depends on: Delivery method - injectable GHK-Cu vs topical GHK-Cu vs oral/sublingual GHK-Cu Goal - skin rejuvenation , hair and scalp support, wound healing , general anti-ageing Individual factors - age , skin type , baseline GHK levels , other peptides being stacked Natural plasma GHK falls from roughly 200 ng/ml at age 20 to around 80 ng/ml by age 60
Research models frequently examine GHK-Cu for its interactions with growth factor signaling, extracellular matrix regulation, and gene expression pathways influenced by copper availability
Those include antihistamines and topical or oral steroids, per Johns Hopkins Medicine
Intravenous use can be very effective, and doesn't cause diarrhea by this route, but this agent must be given extremely carefully, since an error in dosing can shut down the bone marrows production of blood cells, and potentially be fatal
Researchers frequently describe BPC-157 as having anti-inflammatory actions in preclinical contexts
